Drug Profile
Keyhole limpet haemocyanin - Intracel
Alternative Names: BCI-ImmuneActivator; Keyhole limpet hemocyanin; KLHLatest Information Update: 22 Dec 2021
Price :
$50
*
At a glance
- Originator Intracel Corporation
- Class Adjuvants; Antineoplastics; Blood proteins; Metalloproteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bladder cancer; Interstitial cystitis
Most Recent Events
- 22 Feb 2007 No development reported - Phase-III for Bladder cancer in Europe (Intravesicular)
- 22 Feb 2007 Phase-II clinical trials in Interstitial cystitis (unspecified route)
- 22 Dec 2003 Mentor has terminated its licence for keyhole limpet haemocyanin